Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model
Journal of Clinical Laboratory Analysis · 2026
DOI: 10.1002/jcla.70163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Jie Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Capital Health Research and Development of Special Fund, Capital Health Research and Development of Special Fund.
Abstract (Originalsprache)
Objective
To develop and validate a clinical prediction model for differentiating non‐small cell lung cancer (NSCLC) from benign pulmonary diseases (BPD).
Methods
The retrospective study included 226 participants in the training set (134 with NSCLC and 92 with BPD) and 98 participants in the validation set (62 with NSCLC and 36 with BPD). A logistic regression model was constructed using variables such as sex, hemoptysis, serum biomarkers (carcinoembryonic antigen [CEA] and total protein [TP]), and CT features (volume ratio of solid density region [VR_2A], volume of calcified density area [VR_3], total volume [TV], CT variance [CTV], and maximum surface area [MSA]). The model was validated on an independent cohort, and its performance was evaluated using area under the curve (AUC), accuracy, calibration curves, and decision curves. Additionally, a nomogram was developed for clinical application, and its acceptance and convenience among clinicians were assessed.
Results
The prediction model achieved an AUC‐ROC of 0.95 in the training set and 0.82 in the validation set. Calibration and decision curves demonstrated that the model had reliable diagnostic performance and good clinical application value.
Conclusion
The integrated prediction model combining clinical features, laboratory biomarkers, and CT features shows promise for improving the accuracy of differentiating NSCLC from BPD. Further studies are warranted to explore its potential in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
- Department of Imaging, Aerospace Center Hospital, Beijing, China.
ORCID-Profile: Jie Zhang, Mingjian Bai
Förderung
- the Capital Health Research and Development of Special Fund
- Capital Health Research and Development of Special Fund
Zitieren
APA
Zhang, J., Liu, S., Bai, M., Ma, F., Liang, G., & Wang, B. (2026). Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70163
Vancouver
Zhang J, Liu S, Bai M, Ma F, Liang G, Wang B. Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70163
BibTeX
@article{Zhang2026,
author = {Zhang, Jie and Liu, Shui and Bai, Mingjian and Ma, Fucun and Liang, Guowei and Wang, Bing},
title = {Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70163}
}
EUVIMED